Bile acids as markers for testicular germ cell tumors
Treatments studied
Part of Cancer, Hormones & metabolism, Kidney & urinary clinical trials.
This study looks at whether levels of bile acids (substances made by your liver) can help doctors understand how testicular germ cell tumors grow and how they respond to treatment. It may help improve future care for people with this type of cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a male 18 years or older
- You have been diagnosed with a germ cell tumor of the testicle and have not yet had surgery to remove the testicle
- You do not have any liver or bile duct disease
- You are not taking cholestyramine (a medication that binds bile acids)
- You have not had your gallbladder or a large part of your small intestine removed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a simple blood test (liquid biopsy) can help track germ cell tumors (testicular cancer). It may help doctors understand your disease better and guide your care.
This study looks at lab markers (including genetic tests) to predict how people with bile duct cancer respond to treatment. Your answers and samples may help doctors personalize care for bile duct cancer in the future.
This trial looks for signs of cancer DNA in your blood (circulating tumor DNA) to see if it can help track germ cell tumors. It may help doctors find out if your cancer is coming back earlier.
This study looks at tumor tissue samples from people with bile duct or gallbladder cancer to find biomarkers (clues in the tumor) that might help guide future treatment. By studying these samples, researchers hope to understand more about these cancers and improve care.
This study looks at genetic and molecular patterns in people with bile duct or gallbladder cancers, and compares them with people without cancer (or with chronic liver disease). It may help researchers understand why these cancers happen and how to spot risk earlier.
This study looks for new ways to measure cancer-related “biomarkers” (signals in blood or tumor samples) in people with bile duct cancer or gallbladder cancer. The goal is to improve how these cancers are identified and tracked, which could help doctors make better treatment decisions.
Hear when a new Testicular Germ Cell Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.